# CancerAid

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/canceraid-pty

- Industry: Healthcare
- Headquarters: Eveleigh, Australia
- Website: www.canceraid.com/
- Total disclosed funding: $1M
- Latest round: Seed (Oct 3, 2016)
- Investors on record: 1

## About

Founded in 2015 and based in Sydney, Australia, CancerAid Pty Ltd operates as a developer of a cancer-treatment logging mobile application designed to self-manage the treatment process. Raghav Murali-Ganesh is the co-founder and CEO of the company. In October 2016, CancerAid Pty Ltd raised AUD 1.25 million in Series B funding from Clinton Capital Partners.

The company offers a platform to organize a patient's cancer journey and manage awareness and expectations in an individualized way. CancerAid provides an application that gives accurate information specific to the illness, a digital journal, a database for medical records, and access to a global community of people fighting the same disease, enabling patients to find information, caregivers, doctors, and support systems to help them recover. 

The app enables the user to better understand their care, self-manage their treatment, and learn from others in a similar position. The firm offers a symptom tracker which is a symptom reporting tool, where patients can share their symptoms with their clinicians and experience a better quality of life, have fewer emergency visits, and can even live longer.

## Funding rounds

- Seed, Oct 3, 2016, $1M — Clinton Capital Partners

## Investors

- Clinton Capital Partners (https://capitalatlas.ai/funds/clinton-capital-partners) — Seed
